Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Phosphoramidates for the treatment of hepatitis B virus

Phosphoramidates for the treatment of hepatitis B virus

US Patent 11981699 · Granted May 14, 2024

Estimated economic value: $3,179,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted nucleosides and nucleotides for treating viral infections2025
Substituted nucleosides and nucleotides for treating viral infections2025
N4-hydroxycytidine and derivatives and anti-viral uses related thereto2025
N4-hydroxycytidine and derivatives and anti-viral uses related thereto2024
Pharmaceutical compositions comprising substituted nucleotides and nucleosides f2024
Pharmaceutical compositions comprising substituted nucleotides and nucleosides f2024
N4-hydroxycytidine and derivatives and anti-viral uses related thereto2023
Phosphoramidates for the treatment of hepatitis B virus2022
Phosphoramidates for the treatment of hepatitis B virus2022
Phosphoramidates for the treatment of hepatitis B virus2022
Phosphoramidates for the treatment of hepatitis B virus2022
N4-hydroxycytidine and derivatives and anti-viral uses related thereto2022